Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

Early human B cell signatures of the primary antibody response to mRNA vaccination

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

History of SARS-CoV-2 infection affects longitudinal responses to BNT162b2 vaccine

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

JCI - Durable SARS-CoV-2 B cell immunity after mild or severe disease

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

SARS-CoV-2-specific Memory B cells persist up to 8 months post infection.

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

Biomedicines, Free Full-Text

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

Long-term perturbation of the peripheral immune system months after SARS-CoV -2 infection, BMC Medicine

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

COVID-19 Scientific Publications

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

Longitudinal Postvaccine SARS-CoV-2 Immunoglobulin G Titers, Memory B-Cell Responses, and Risk of COVID-19 in Multiple Sclerosis Over 1 Year

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection - eBioMedicine

Immunological memory to SARS-CoV-2 assessed for up to 8 months after  infection

Frontiers SARS-CoV-2 Variants, Vaccines, and Host Immunity